These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2473987)

  • 1. Binding of hexabrachions to heparin and DNA.
    Marton LS; Gulcher JR; Stefansson K
    J Biol Chem; 1989 Aug; 264(22):13145-9. PubMed ID: 2473987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of hexabrachion (tenascin) to the extracellular matrix and substratum and its effect on cell adhesion.
    Lightner VA; Erickson HP
    J Cell Sci; 1990 Feb; 95 ( Pt 2)():263-77. PubMed ID: 1695220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell- and heparin-binding domains of the hexabrachion arm identified by tenascin expression proteins.
    Aukhil I; Joshi P; Yan Y; Erickson HP
    J Biol Chem; 1993 Feb; 268(4):2542-53. PubMed ID: 7679097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The core protein of the matrix-associated heparan sulfate proteoglycan binds to fibronectin.
    Heremans A; De Cock B; Cassiman JJ; Van den Berghe H; David G
    J Biol Chem; 1990 May; 265(15):8716-24. PubMed ID: 2140362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin.
    Jalkanen S; Jalkanen M
    J Cell Biol; 1992 Feb; 116(3):817-25. PubMed ID: 1730778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of contactin/F11 to the fibronectin type III domains 5 and 6 of tenascin is inhibited by heparin.
    Weber P; Ferber P; Fischer R; Winterhalter KH; Vaughan L
    FEBS Lett; 1996 Jul; 389(3):304-8. PubMed ID: 8766721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acylation of gelatin-agarose and the enhancement by heparin of fibronectin binding.
    Smith RL; Griffin CA
    Arch Biochem Biophys; 1988 Oct; 266(1):181-8. PubMed ID: 3178220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single heparin binding region within the fibrinogen-like domain is functional in chick tenascin-C.
    Fischer D; Chiquet-Ehrismann R; Bernasconi C; Chiquet M
    J Biol Chem; 1995 Feb; 270(7):3378-84. PubMed ID: 7531705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hemopexin-like domain (C domain) of human gelatinase A (matrix metalloproteinase-2) requires Ca2+ for fibronectin and heparin binding. Binding properties of recombinant gelatinase A C domain to extracellular matrix and basement membrane components.
    Wallon UM; Overall CM
    J Biol Chem; 1997 Mar; 272(11):7473-81. PubMed ID: 9054449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of chondroitin sulfates on brain-derived tenascin-R in carbohydrate-dependent interactions with fibronectin and tenascin-C.
    Probstmeier R; Braunewell K; Pesheva P
    Brain Res; 2000 Apr; 863(1-2):42-51. PubMed ID: 10773191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The heparin III-binding domain of fibronectin (III4-5 repeats) binds to fibronectin and inhibits fibronectin matrix assembly.
    Maqueda A; Moyano JV; Hernández Del Cerro M; Peters DM; Garcia-Pardo A
    Matrix Biol; 2007 Oct; 26(8):642-51. PubMed ID: 17611093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA-binding domains of human plasma fibronectin. pH and calcium ion modulation of fibronectin binding to DNA and heparin.
    Siri A; Balza E; Carnemolla B; Castellani P; Borsi L; Zardi L
    Eur J Biochem; 1986 Feb; 154(3):533-8. PubMed ID: 3948864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity in the interactions of extracellular matrix proteins with subpopulations of the glycosaminoglycan heparin.
    San Antonio JD; Slover J; Lawler J; Karnovsky MJ; Lander AD
    Biochemistry; 1993 May; 32(18):4746-55. PubMed ID: 8490019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human neuroectoderm-derived cell line secretes fibronectin that shares the HNK-1/10C5 carbohydrate epitope with neural cell adhesion molecules.
    Harper JR; Perry SK; Davis RM; Laufer DM
    J Neurochem; 1990 Feb; 54(2):395-401. PubMed ID: 1688916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tenascin-contactin/F11 interactions: a clue for a developmental role?
    Vaughan L; Weber P; D'Alessandri L; Zisch AH; Winterhalter KH
    Perspect Dev Neurobiol; 1994; 2(1):43-52. PubMed ID: 7530143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complexing of fibronectin glycosaminoglycans and collagen.
    Ruoslahti E; Engvall E
    Biochim Biophys Acta; 1980 Aug; 631(2):350-8. PubMed ID: 7407251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification of hexabrachion (tenascin) from cell culture conditioned medium, and separation from a cell adhesion factor.
    Aukhil I; Slemp CC; Lightner VA; Nishimura K; Briscoe G; Erickson HP
    Matrix; 1990 May; 10(2):98-111. PubMed ID: 1695709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and structural studies of tenascin/hexabrachion proteins.
    Taylor HC; Lightner VA; Beyer WF; McCaslin D; Briscoe G; Erickson HP
    J Cell Biochem; 1989 Oct; 41(2):71-90. PubMed ID: 2482292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of fibronectin binding to matrix components by nonenzymatic glycosylation.
    Cohen MP; Ku L
    Diabetes; 1984 Oct; 33(10):970-4. PubMed ID: 6479461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tenascin-C binds heparin by its fibronectin type III domain five.
    Weber P; Zimmermann DR; Winterhalter KH; Vaughan L
    J Biol Chem; 1995 Mar; 270(9):4619-23. PubMed ID: 7533163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.